Pharmacist-Driven Culture and Sexually Transmitted Infection Testing Follow-Up Program in the Emergency Department
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Setting
2.2. Study Design
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
Appendix A
References
- The Joint Commission Department of Standards and Survey Methods. Approved: New Antimicrobial Stewardship Standard. Jt. Comm. Perspect. 2016, 36, 1–8. [Google Scholar]
- Center for Disease Control and Prevention. Core Elements of Outpatient Antimicrobial Stewardship. Available online: www.cdc.gov/antibiotic-use/community/pdfs/16_268900-A_CoreElementsOutpatient_appendix_508.pdf (accessed on 1 August 2018).
- Drekonja, D.M.; Filice, G.A.; Greer, N.; Olson, A.; MacDonald, R.; Rutks, I.; Wilt, T.J. Antimicrobial stewardship in outpatient settings: A systematic review. Infect. Control Hosp. Epidemiol. 2015, 36, 142–152. [Google Scholar] [CrossRef] [PubMed]
- Centers for Disease Control. Antibiotic Resistance Threats in the United States; CDC: Atlanta, GA, USA, 2013. Available online: www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf (accessed on 1 August 2018).
- Seddon, M.M.; Bookstaver, P.B.; Justo, J.A.; Kohn, J.; Rac, H.; Haggard, E.; Mediwala, K.N.; Dash, S.; Al-Hasan, M.N. Role of early de-escalation of antimicrobial therapy on risk of Clostridioides difficile infection following Enterobacteriaceae bloodstream infections. Clin. Infect. Dis. 2019, 69, 414–420. [Google Scholar] [CrossRef] [PubMed]
- Jorgensen, S.C.; Yeung, S.L.; Zurayk, M.; Terry, J.; Dunn, M.; Nieberg, P.; Pallares, J.; Wong-Beringer, A. Leveraging Antimicrobial Stewardship in the ED to Improve the Quality of Urinary Tract Infection Management and Outcomes. Open Forum Infect. Dis. 2018, 5, ofy101. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dumkow, L.E.; Kenney, R.M.; MacDonald, N.C.; Carreno, J.J.; Malhotra, M.K.; Davis, S.L. Impact of a Multidiscinplinary Culture Follow-up Program of Antimicrobial Therpay in the ED. Infect. Dis. Ther. 2014, 3, 45–52. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Randolph, T.C.; Parker, A.; Meyer, L.; Zeina, R. Effect of a pharmacist-managed culture review process on antimicrobial therapy in an ED. Am. J. Health-Syst. Pharm. 2011, 68, 916–919. [Google Scholar] [CrossRef] [PubMed]
- Baker, S.N.; Acquisto, N.M.; Ashley, E.D.; Fairbanks, R.J.; Beamish, S.E.; Haas, C.E. Pharmacist-managed antimicrobial stewardship program for patients discharged from the ED. J. Pharm. Pract. 2012, 25, 190–194. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Olson, A.; Pegelow, E.; Cowell, J.; Feldman, R.; Stanton, M.; Ray, J.; Dang, C. Pharmacist-Initiated Culture Follow-Up in the ED Reduces Time to Treatment Optimization. Ann. Emerg. Med. 2017, 70, S61. [Google Scholar] [CrossRef]
- May, L.; Tancredi, D.; Mooso, B.; Nguyen, M.; Ondak, S.; Anderson, C.; Briggs, J.; Luong, L.; Miller, L.G. An ED Antimicrobial Stewardship Intervention to Improve Antibiotic Selection and Duration for Skin and Soft-tissue infections in Adult and Pediatric Outpatients. Open Forum Infect. Dis. 2018, 5, S97–S98. [Google Scholar] [CrossRef]
- Bookstaver, P.B.; Jenkins, T.C.; Stenehjem, E.; Doron, S.; Brown, J.; Goldwater, S.H.; Lopes, C.; Haynes, A.; Udeze, C.; Mo, Y.; et al. Impact of Outpatient vs Inpatient ABSSSI Treatment on Outcomes: A Retrospective Observational Analysis of Medical Charts Across US EDs. Open Forum Infect. Dis. 2018, 5, ofy109. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fay, L.N.; Wolf, L.M.; Brandt, K.L.; DeYoung, G.R.; Anderson, A.M.; Egwuatu, N.E.; Dumkow, L.E. Pharmacist-led antimicrobial stewardship program in an urgent care setting. Am. J. Health Syst. Pharm. 2019, 76, 175–181. [Google Scholar] [CrossRef] [PubMed]
- Kong, F.Y.S.; Tabrizi, S.N.; Law, M.; Vodstrcil, L.A.; Chen, M.; Fairley, C.K.; Guy, R.; Bradshaw, C.; Hocking, J.S. Azithromycin versus doxycycline for the treatment of genital chlamydia infection: A meta-analysis of randomized controlled trials. Clin. Infect. Dis. 2014, 59, 193–205. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Center for Disease Control and Prevention 2015 Sexually Transmitted Diseases Treatment Guidelines. Available online: www.cdc.gov/std/tg2015/gonorrhea.htm (accessed on 15 July 2019).
- Bahr, S.J.; Solverson, S.; Schlidt, A.; Hack, D.; Smith, J.L.; Ryan, P. Integrated Literature Review of Post discharge Telephone Calls. West J. Nurs. Res. 2014, 36, 84–104. [Google Scholar] [CrossRef] [PubMed]
- Dan, S.; Shah, A.; Justo, J.A.; Bookstaver, P.B.; Kohn, J.; Albrecht, H.; Al-Hasan, M.N. Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections. Antimicrob. Agents Chemother. 2016, 60, 2265–2272. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- DeMarsh, M.; Bookstaver, P.B.; Gordon, C.; Lim, J.; Griffith, N.; Bookstaver, N.K.; Justo, J.A.; Kohn, J.; Al-Hasan, M.N. Prediction of Sulfamethoxazole/Trimethoprim Resistance in Community-Onset Urinary Tract Infections. J. Glob. Antimicrob. Resist. 2019. [Google Scholar] [CrossRef] [PubMed]
Baseline Characteristic, n (%) | Pre-Implementation, n = 64 | Post-Implementation, n = 63 | p-Value |
---|---|---|---|
Mean age, years (standard deviation) | 50.67 (23.4) | 42.40 (24.0) | 0.028 |
Female gender | 51 (79.69) | 51 (80.95) | 1 |
Result type | 0.17 | ||
Urine | 46 (71.9) | 36 (57.1) | |
PCR/molecular testing 1 | 15 (23.4) | 24 (38.1) | |
Blood cultures | 3 (4.7) | 3 (4.8) | |
Antibiotic provided upon ED discharge | 0.35 2 | ||
Nitrofurantoin | 4 (6.3) | 7 (11.1) | |
Sulfamethoxazole/trimethoprim | 9 (14.1) | 3 (4.8) | |
Clindamycin | 0 | 1 (1.6) | |
Metronidazole | 9 (14.1) | 6 (9.5) | |
No antibiotic | 38 (59.4) | 38 (60.3) | |
Other | 1 (1.6) | 0 | |
Beta-lactam | 1 (1.6) | 2 (3.2) | 0.62 |
Fluoroquinolone | 2 (3.1) | 4 (6.4) | 0.44 |
Type of Intervention, n (%) | Pre-Implementation, n = 64 | Post-Implementation, n = 63 | p-Value |
---|---|---|---|
Initiation of therapy | 25 (39) | 19 (30.2) | 0.39 |
Modification of therapy | 24 (37.5) | 14 (22.2) | 0.09 |
Contact primary care provider | 4 (6.3) | 8 (12.7) | 0.35 |
Contact nursing home | 5 (7.8) | 7 (11.1) | 0.74 |
No medication 1 | 5 (7.8) | 5 (7.9) | 1 |
Letter sent | 3 (4.7) | 12 (19) | 0.026 |
Outcome, n (%) | Pre-implementation, n = 64 | Post-implementation, n = 63 | p-Value |
---|---|---|---|
Patients with repeat ED encounter within 30 days | 10 (15.6) | 12 (19.1) | 0.783 |
Patients with repeat ED encounter related to index case | 5 (7.3) | 0 | -- |
Patients with hospital admissions within 30 days | 6 (9.4) | 5 (7.9) | 1 |
Patients with unintended repeat hospital admission related to index case | 2 (2.9) | 1 (1.7) | -- |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Shealy, S.C.; Alexander, C.; Hardison, T.G.; Magagnoli, J.; Justo, J.A.; Derrick, C.; Kohn, J.; Winders, H.R.; Privette, T.; Al-Hasan, M.N.; et al. Pharmacist-Driven Culture and Sexually Transmitted Infection Testing Follow-Up Program in the Emergency Department. Pharmacy 2020, 8, 72. https://doi.org/10.3390/pharmacy8020072
Shealy SC, Alexander C, Hardison TG, Magagnoli J, Justo JA, Derrick C, Kohn J, Winders HR, Privette T, Al-Hasan MN, et al. Pharmacist-Driven Culture and Sexually Transmitted Infection Testing Follow-Up Program in the Emergency Department. Pharmacy. 2020; 8(2):72. https://doi.org/10.3390/pharmacy8020072
Chicago/Turabian StyleShealy, Stephanie C., Christine Alexander, Tina Grof Hardison, Joseph Magagnoli, Julie Ann Justo, Caroline Derrick, Joseph Kohn, Hana Rac Winders, Troy Privette, Majdi N. Al-Hasan, and et al. 2020. "Pharmacist-Driven Culture and Sexually Transmitted Infection Testing Follow-Up Program in the Emergency Department" Pharmacy 8, no. 2: 72. https://doi.org/10.3390/pharmacy8020072